LPL Financial
DFTX

LPL Financial’s Definium Therapeutics DFTX Stock Holding History

LPL Financial’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.05M Buy
86,136
+7,865
+10% +$194K ﹤0.01% 2994
2026
Q1 		$1.48M Buy
78,271
+1,035
+1% +$17.6K ﹤0.01% 3799
2025
Q4 		$1.03M Buy
77,236
+1,289
+2% +$16K ﹤0.01% 4043
2025
Q3 		$895K Buy
75,947
+7,458
+11% +$69.6K ﹤0.01% 4104
2025
Q2 		$444K Buy
68,489
+1,056
+2% +$6.95K ﹤0.01% 4469
2025
Q1 		$394K Buy
67,433
+5,099
+8% +$36.5K ﹤0.01% 4374
2024
Q4 		$434K Buy
62,334
+14,439
+30% +$99.3K ﹤0.01% 4216
2024
Q3 		$273K Buy
47,895
+1,630
+4% +$11.3K ﹤0.01% 4510
2024
Q2 		$334K Buy
46,265
+2,538
+6% +$22.2K ﹤0.01% 4185
2024
Q1 		$411K Buy
43,727
+8,497
+24% +$48.5K ﹤0.01% 3936
2023
Q4 		$129K Buy
35,230
+14,079
+67% +$42.4K ﹤0.01% 4505
2023
Q3 		$66.2K Buy
21,151
+316
+2% +$1.3K ﹤0.01% 4482
2023
Q2 		$74.4K Buy
20,835
+3
+0% +$10 ﹤0.01% 4379
2023
Q1 		$66K Buy
20,832
+2,277
+12% +$7.57K ﹤0.01% 4272
2022
Q4 		$40.8K Buy
18,555
+668
+4% +$1.85K ﹤0.01% 4294
2022
Q3 		$63K Sell
17,887
-33,760
-65% -$324K ﹤0.01% 4200
2022
Q2 		$496K Buy
+51,647
New +$653K ﹤0.01% 3207
2022
Q1 		– Sell
-25,814
Closed -$534K – 4322
2021
Q4 		$534K Buy
25,814
+22,888
+782% +$731K ﹤0.01% 3221
2021
Q3 		$102K Sell
2,926
-19
-0.6% -$821 ﹤0.01% 4139
2021
Q2 		$152K Buy
+2,945
New +$155K ﹤0.01% 3974

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

LPL Financial's DFTX Position: Q2 2026 in Review

LPL Financial increased its Definium Therapeutics (DFTX) stake by 10% in Q2 2026, buying an estimated $194K and bringing the position to 86,136 shares worth $4.05M. The position accounts for ﹤0.01% of the portfolio, ranked #2994.

LPL Financial first reported a position in DFTX in Q2 2021 and has held it in 20 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • LPL Financial held 86,136 shares of Definium Therapeutics worth $4.05M as of Q2 2026.
  • LPL Financial bought 7,865 Definium Therapeutics shares in Q2 2026, an estimated $194K.
  • Definium Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #2994 holding.
  • LPL Financial first reported a position in Definium Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.